Financials
Financial year 2025
REMBRANDT MEDICAL from Nazareth, company number BE0477901182, closed financial year 2025 with a result of € 141,270 after tax. For that financial year REMBRANDT MEDICAL recorded a gross margin of € 541,971 and equity of € 346,178. Compared with financial year 2024, the result moved from € 142,168 to € 141,270. The company is profitable. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 346,178
▼ 15% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 141,270
▼ 1% vs 2024
Profit after tax over the fiscal year.
€ 374,608
▼ 32% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 200,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
3.5
Average over the fiscal year, from the social balance sheet.
€ 329,451
€ 94,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 15,976
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 138,279
▼ 35% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 80,199
▼ 24% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 351,240 | € 629,667 | € 543,993 | € 541,971 | |
| Profit after taxes | € 48,487 | € 230,217 | € 142,168 | € 141,270 | ▼ 1% |
| Equity | € 232,524 | € 262,741 | € 404,909 | € 346,178 | ▼ 15% |
| Total debts | € 484,905 | € 640,100 | € 746,686 | € 736,328 | ▼ 1% |
| Cash | € 298,000 | € 453,206 | € 553,131 | € 374,608 | ▼ 32% |
| Retained profit | € 157,524 | € 187,741 | € 329,909 | € 271,178 | ▼ 18% |
| Dividend | € 0 | € 200,000 | € 0 | € 200,000 | |
| Balance sheet total | € 717,429 | € 902,840 | € 1,151,595 | € 1,082,506 | ▼ 6% |
| Employees (FTE) | 3.5 | 3.5 | 3.5 | 3.5 |
Key figures of REMBRANDT MEDICAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to REMBRANDT MEDICAL?
What happened at REMBRANDT MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Musters Carolus stepped down as director. NBB
- Sander Alma stepped down as director. NBB
- Nathalie Depuydt stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 141,270 (▼ 1% vs 2024). filed late Source: NBB ↗
- Musters Carolus became a director. NBB
- Sander Alma became a director. NBB
- Nathalie Depuydt became a director. NBB
- New establishment in Gent. KBO
In short
From € 48,487 profit in 2022 to € 141,270 profit in 2025.
Paid € 219,098 in corporate taxes since 2022.
Best year ever: 2023, with € 230,217 profit.
On average € 154,800 of value added per employee in 2025.
A new publication or filing at REMBRANDT MEDICAL? We notify you, reason included.
Follow REMBRANDT MEDICALDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2025 annual accounts
Musters Carolus
Persoon belast met dagelijks bestuur
since 2024 · until 2030
Sander Alma
Director
since 2024 · until 2030
Nathalie Depuydt
Managing director
since 2024 · until 2030
Establishments
Establishment units
Physical locations of this company
Drapstraat 93 box A
9810 Nazareth
Loofblommestraat 58
9051 Gent
Active since 19 July 2002
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Certifications & Partners
Hosting & Email
Email provider
Microsoft 365
Hosting
OVH, FR
DNS
OVH DNS
Website info
Features
Security
Network
Details
- Company number
- 0477.901.182
- VAT number
- BE 0477.901.182
- Registered office
- Drapstraat 93 bus A, 9810 Nazareth
- Names & denominations
- REMBRANDT MEDICAL
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 28 June 2002
- Peppol
- Active · Active since 20 Nov 2020
- Contact
- rembrandtmedical.be
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Groothandel in farmaceutische producten
Handelsbemiddeling in de niet-gespecialiseerde groothandel
Handelsbemiddeling in goederen, algemeen assortiment